NHAS
Novo Holdings A/S’s Corvus Pharmaceuticals CRVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-847,906
| Closed | -$3.02M | – | 52 |
|
|
2020
Q4 | $3.02M | Sell |
847,906
-541,592
| -39% | -$1.93M | 0.13% | 44 |
|
|
2020
Q3 | $5.57M | Sell |
1,389,498
-1,538,062
| -53% | -$6.17M | 0.28% | 37 |
|
|
2020
Q2 | $7.96M | Hold |
2,927,560
| – | – | 0.51% | 25 |
|
|
2020
Q1 | $6.18M | Hold |
2,927,560
| – | – | 0.41% | 18 |
|
|
2019
Q4 | $15.9M | Hold |
2,927,560
| – | – | 1.03% | 14 |
|
|
2019
Q3 | $8.81M | Sell |
2,927,560
-1,492,956
| -34% | -$4.49M | 1.51% | 15 |
|
|
2019
Q2 | $16.5M | Hold |
4,420,516
| – | – | 2.32% | 11 |
|
|
2019
Q1 | $17.8M | Hold |
4,420,516
| – | – | 2.63% | 9 |
|
|
2018
Q4 | $16.2M | Hold |
4,420,516
| – | – | 2.28% | 10 |
|
|
2018
Q3 | $37.9M | Hold |
4,420,516
| – | – | 3.01% | 3 |
|
|
2018
Q2 | $48.5M | Hold |
4,420,516
| – | – | 4.88% | 3 |
|
|
2018
Q1 | $51M | Buy |
4,420,516
+1,176,470
| +36% | +$13.6M | 6.39% | 4 |
|
|
2017
Q4 | $33.6M | Hold |
3,244,046
| – | – | 4.71% | 4 |
|
|
2017
Q3 | $51.7M | Hold |
3,244,046
| – | – | 6.73% | 4 |
|
|
2017
Q2 | $39.3M | Buy |
3,244,046
+20,000
| +0.6% | +$242K | 4.7% | 6 |
|
|
2017
Q1 | $67M | Hold |
3,224,046
| – | – | 7.13% | 5 |
|
|
2016
Q4 | $46.1M | Hold |
3,224,046
| – | – | 4.39% | 7 |
|
|
2016
Q3 | $53M | Hold |
3,224,046
| – | – | 4.71% | 7 |
|
|
2016
Q2 | $46M | Buy |
3,224,046
+70,000
| +2% | +$998K | 4.83% | 6 |
|
|
2016
Q1 | $45.7M | Buy |
+3,154,046
| New | +$45.7M | 5.01% | 5 |
|